Diaz-Llopis, Manuel García-Delpech, Salvador Salom, David Udaondo, Patricia Hernández-Garfella, Marisa Bosch-Morell, Francisco Quijada, Arturo Romero, Francisco J
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
The aim of this study was to assess the efficacy and safety of adalimumab in treating refractory autoimmune uveitis. This work was a prospective, noncomparative, nonrandomized, clinical trial. Nineteen (19) patients meeting eligibility criteria received a 40-mg subcutaneous (s.c.) injection of adalimumab every other week during 1 year. All patients...
Fujita, Eriko Teramura, Yoshinori Shiraga, Toshifumi Yoshioka, Shin-Ichi Iwatsubo, Takafumi Kawamura, Akio Kamimura, Hidetaka
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
The aim of this study was to investigate the ocular distribution of tacrolimus (FK506) and absorption into the systemic circulation after a single or repeated topical instillation of FK506 ophthalmic suspension in male New Zealand white rabbits. In the single instillation study (group 1), 29.1-34.8 microL of a 0.1, 0.3, and 1% suspension was admini...
Khanani, Arshad M Brown, Sandra M
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Yalçindağ, F Nilüfer Amer, Radgonde Forrester, John V
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Our study suggests that mycophenolate mofetil may be a safe, effective therapeutic modality for ocular inflammation associated with ANCA-associated vasculitis.
Fei, Wen-Lei Chen, Jia-Qi Yuan, Jin Quan, Da-Ping Zhou, Shi-You
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
FK506 0.01% nanospheric-suspension eye drops delayed the occurrence of corneal allograft rejection and prolonged allograft survival time. The FK506 nanospheres may be valuable in suppressing corneal graft rejection.
Radi, Zaher A Render, James A
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Cyclooxygenase isoenzymes (COX-1 and -2) catalyze the conversion of arachidonic acid to prostaglandins (PGs) and play a significant role in the health and disease of the eye. Experimental animal models of ocular diseases have been used to assess the effects of the selective COX inhibitors (COXIBs), and nonselective, nonsteroidal anti-inflammatory d...
Lin, Richard C Sanduja, Neeraj Hariprasad, Seenu M
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
The combination of anterior chamber washout, pars plana vitrectomy, and intracameral and intravitreal voriconazole injection is a viable therapeutic option in cases of fungal endophthalmitis.
Abd-El-Barr, Muhammad M Albini, Thomas A Carvounis, Petros E He, Feng Manzano, Roberta P A Chevez-Barrios, Patricia Wensel, Theodore G Wu, Samuel M Holz, Eric R
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
The half-life of commercially available TH in the vitreous is double that of TA, but the former is toxic to the retina in this rabbit model. Reformulated iso-osmolar TH showed no evidence of deleterious effects to retina function or structure but had a similar half-life to TA.
Giannola, Libero I de Caro, Viviana Giandalia, Giulia Siragusa, Maria G Cordone, Lorenzo
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Adequate drug concentrations in aqueous humor could be prolonged after the administration of TRH/NAT/NOR microspheres. Good bioadhesive properties of the system and slow drug release on corneal surface might increase ocular NOR bioavailability.
Afshari, Natalie A Ma, Joseph J K Duncan, Scott M Pineda, Roberto Starr, Christopher E Decroos, Francis Char Johnson, Carl S Adelman, Ron A
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
There was increased resistance of gram-positive organisms to ciprofloxacin and cefazolin, but not gentamicin, in the two examined time periods. Increased resistance to these commonly used antibiotics emphasizes the need for close follow-up after initial empiric treatment, and maintaining a low threshold for selecting alternative therapy.